112 related articles for article (PubMed ID: 6142598)
1. Selective anxiolytics: are the actions related to partial "agonist" activity or a preferential affinity for benzodiazepine receptor subtypes?
Gee KW; Yamamura HI
Adv Biochem Psychopharmacol; 1983; 38():1-9. PubMed ID: 6142598
[TBL] [Abstract][Full Text] [Related]
2. Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one].
Licata SC; Platt DM; Cook JM; Sarma PV; Griebel G; Rowlett JK
J Pharmacol Exp Ther; 2005 Jun; 313(3):1118-25. PubMed ID: 15687371
[TBL] [Abstract][Full Text] [Related]
3. GABA A receptor subtype selectivity underlying selective anxiolytic effect of baicalin.
Wang F; Xu Z; Ren L; Tsang SY; Xue H
Neuropharmacology; 2008 Dec; 55(7):1231-7. PubMed ID: 18723037
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors.
Cox ED; Diaz-Arauzo H; Huang Q; Reddy MS; Ma C; Harris B; McKernan R; Skolnick P; Cook JM
J Med Chem; 1998 Jul; 41(14):2537-52. PubMed ID: 9651158
[TBL] [Abstract][Full Text] [Related]
5. Binding of a radiolabeled triazolopyridazine to a subtype of benzodiazepine receptor in the rat cerebellum.
Niehoff DL; Mashal RD; Horst WD; O'Brien RA; Palacios JM; Kuhar MJ
J Pharmacol Exp Ther; 1982 Jun; 221(3):670-5. PubMed ID: 6283058
[TBL] [Abstract][Full Text] [Related]
6. Selectivity for omega-receptor subtypes as a strategy for the development of anxiolytic drugs.
Langer SZ; Arbilla S; Tan S; Lloyd KG; George P; Allen J; Wick AE
Pharmacopsychiatry; 1990 May; 23 Suppl 3():103-7. PubMed ID: 1974068
[TBL] [Abstract][Full Text] [Related]
7. New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.
Griebel G; Perrault G; Letang V; Granger P; Avenet P; Schoemaker H; Sanger DJ
Psychopharmacology (Berl); 1999 Sep; 146(2):205-13. PubMed ID: 10525757
[TBL] [Abstract][Full Text] [Related]
8. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
[TBL] [Abstract][Full Text] [Related]
9. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
10. The involvement of the benzodiazepine receptor in hepatic encephalopathy: evidence for the presence of a benzodiazepine receptor ligand.
Basile AS; Ostrowski NL; Gammal SH; Jones EA; Skolnick P
Adv Biochem Psychopharmacol; 1990; 46():189-200. PubMed ID: 1963266
[TBL] [Abstract][Full Text] [Related]
11. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.
McKernan RM; Rosahl TW; Reynolds DS; Sur C; Wafford KA; Atack JR; Farrar S; Myers J; Cook G; Ferris P; Garrett L; Bristow L; Marshall G; Macaulay A; Brown N; Howell O; Moore KW; Carling RW; Street LJ; Castro JL; Ragan CI; Dawson GR; Whiting PJ
Nat Neurosci; 2000 Jun; 3(6):587-92. PubMed ID: 10816315
[TBL] [Abstract][Full Text] [Related]
12. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.
Revel L; Mennuni L; Garofalo P; Makovec F
Behav Pharmacol; 1998 May; 9(3):183-94. PubMed ID: 9832933
[TBL] [Abstract][Full Text] [Related]
13. A novel selective GABA(A) alpha1 receptor agonist displaying sedative and anxiolytic-like properties in rodents.
Selleri S; Bruni F; Costagli C; Costanzo A; Guerrini G; Ciciani G; Gratteri P; Besnard F; Costa B; Montali M; Martini C; Fohlin J; De Siena G; Aiello PM
J Med Chem; 2005 Oct; 48(21):6756-60. PubMed ID: 16220991
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological evidence that PK 8165 behaves as a partial agonist of brain type benzodiazepine receptors.
Mizoule J; Rataud J; Uzan A; Mazadier M; Daniel M; Gauthier A; Ollat C; Gueremy C; Renault C; Dubroeucq MC
Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):189-97. PubMed ID: 6095778
[TBL] [Abstract][Full Text] [Related]
15. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM
J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
[TBL] [Abstract][Full Text] [Related]
16. Benzodiazepine receptors are coupled to a subpopulation of gamma-aminobutyric acid (GABA) receptors: evidence from a quantitative autoradiographic study.
Unnerstall JR; Kuhar MJ; Niehoff DL; Palacios JM
J Pharmacol Exp Ther; 1981 Sep; 218(3):797-804. PubMed ID: 6267249
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of the pyrazolo-type compounds: agonist, antagonist and inverse agonist actions.
Bennett DA
Physiol Behav; 1987; 41(3):241-5. PubMed ID: 2893398
[TBL] [Abstract][Full Text] [Related]
18. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors.
Rowlett JK; Spealman RD; Lelas S; Cook JM; Yin W
Psychopharmacology (Berl); 2003 Jan; 165(3):209-15. PubMed ID: 12420154
[TBL] [Abstract][Full Text] [Related]
20. Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment.
Smith TA
Br J Biomed Sci; 2001; 58(2):111-21. PubMed ID: 11440203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
